Literature DB >> 25678598

MAPK7 Regulates EMT Features and Modulates the Generation of CTCs.

Sarah Javaid1, Jianmin Zhang2, Gromoslaw A Smolen2, Min Yu2, Ben S Wittner1, Anurag Singh2, Kshitij S Arora2, Marissa W Madden2, Rushil Desai2, Matthew J Zubrowski2, Benjamin J Schott2, David T Ting1, Shannon L Stott3, Mehmet Toner4, Shyamala Maheswaran5, Toshi Shioda1, Sridhar Ramaswamy1, Daniel A Haber6.   

Abstract

UNLABELLED: Epithelial-to-mesenchymal transition (EMT) has been implicated in models of tumor cell migration, invasion, and metastasis. In a search for candidate therapeutic targets to reverse this process, nontumorigenic MCF10A breast epithelial cells were infected with an arrayed lentiviral kinome shRNA library and screened for either suppression or enhancement of a 26-gene EMT RNA signature. No individual kinase gene knockdown was sufficient to induce EMT. In contrast, grouped epithelial markers were induced by knockdown of multiple kinases, including mitogen activated protein kinase 7 (MAPK7). In breast cancer cells, suppression of MAPK7 increased E-cadherin (CDH1) expression and inhibited cell migration. In an orthotopic mouse model, MAPK7 suppression reduced the generation of circulating tumor cells and the appearance of lung metastases. Together, these observations raise the possibility that targeting kinases that maintain mesenchymal cell properties in cancer cells, such as MAPK7, may lessen tumor invasiveness. IMPLICATIONS: Suppression of MAPK7 induces epithelial markers, reduces generation of circulating tumor cells and appearance of lung metastases. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25678598      PMCID: PMC4433453          DOI: 10.1158/1541-7786.MCR-14-0604

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  48 in total

Review 1.  The Snail genes as inducers of cell movement and survival: implications in development and cancer.

Authors:  Alejandro Barrallo-Gimeno; M Angela Nieto
Journal:  Development       Date:  2005-07       Impact factor: 6.868

2.  A genetic screen for candidate tumor suppressors identifies REST.

Authors:  Thomas F Westbrook; Eric S Martin; Michael R Schlabach; Yumei Leng; Anthony C Liang; Bin Feng; Jean J Zhao; Thomas M Roberts; Gail Mandel; Gregory J Hannon; Ronald A Depinho; Lynda Chin; Stephen J Elledge
Journal:  Cell       Date:  2005-06-17       Impact factor: 41.582

Review 3.  Complex networks orchestrate epithelial-mesenchymal transitions.

Authors:  Jean Paul Thiery; Jonathan P Sleeman
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

Review 4.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

Authors:  Jing Yang; Robert A Weinberg
Journal:  Dev Cell       Date:  2008-06       Impact factor: 12.270

5.  Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures.

Authors:  Jayanta Debnath; Senthil K Muthuswamy; Joan S Brugge
Journal:  Methods       Date:  2003-07       Impact factor: 3.608

6.  Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition.

Authors:  Masato Maeda; Keith R Johnson; Margaret J Wheelock
Journal:  J Cell Sci       Date:  2005-02-15       Impact factor: 5.285

7.  Genes that mediate breast cancer metastasis to lung.

Authors:  Andy J Minn; Gaorav P Gupta; Peter M Siegel; Paula D Bos; Weiping Shu; Dilip D Giri; Agnes Viale; Adam B Olshen; William L Gerald; Joan Massagué
Journal:  Nature       Date:  2005-07-28       Impact factor: 49.962

8.  A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen.

Authors:  Jason Moffat; Dorre A Grueneberg; Xiaoping Yang; So Young Kim; Angela M Kloepfer; Gregory Hinkle; Bruno Piqani; Thomas M Eisenhaure; Biao Luo; Jennifer K Grenier; Anne E Carpenter; Shi Yin Foo; Sheila A Stewart; Brent R Stockwell; Nir Hacohen; William C Hahn; Eric S Lander; David M Sabatini; David E Root
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

9.  Multifunctional role of Erk5 in multiple myeloma.

Authors:  Xonia Carvajal-Vergara; Soraya Tabera; Juan C Montero; Azucena Esparís-Ogando; Ricardo López-Pérez; Gema Mateo; Norma Gutiérrez; Marisa Parmo-Cabañas; Joaquín Teixidó; Jesús F San Miguel; Atanasio Pandiella
Journal:  Blood       Date:  2005-02-03       Impact factor: 22.113

10.  E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines.

Authors:  M Lombaerts; T van Wezel; K Philippo; J W F Dierssen; R M E Zimmerman; J Oosting; R van Eijk; P H Eilers; B van de Water; C J Cornelisse; A-M Cleton-Jansen
Journal:  Br J Cancer       Date:  2006-03-13       Impact factor: 7.640

View more
  21 in total

Review 1.  Oncogenic signaling of MEK5-ERK5.

Authors:  Van T Hoang; Thomas J Yan; Jane E Cavanaugh; Patrick T Flaherty; Barbara S Beckman; Matthew E Burow
Journal:  Cancer Lett       Date:  2017-01-30       Impact factor: 8.679

Review 2.  Phenotype of circulating tumor cell: face-off between epithelial and mesenchymal masks.

Authors:  Yupeng Hong; Qi Zhang
Journal:  Tumour Biol       Date:  2016-01-13

3.  The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.

Authors:  Emne A Abdallah; Alexcia C Braun; Bianca C T C P Flores; Laís Senda; Ana Cláudia Urvanegia; Vinicius Calsavara; Victor Hugo Fonseca de Jesus; Maria Fernanda Arruda Almeida; Maria Dirlei Begnami; Felipe J F Coimbra; Wilson Luiz da Costa; Diana Noronha Nunes; Emmanuel Dias-Neto; Ludmilla T Domingos Chinen
Journal:  Oncologist       Date:  2019-03-07

4.  A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.

Authors:  Simona Pavan; Nathalie Meyer-Schaller; Maren Diepenbruck; Ravi Kiran Reddy Kalathur; Meera Saxena; Gerhard Christofori
Journal:  Oncogene       Date:  2018-05-01       Impact factor: 9.867

5.  The extracellular-regulated protein kinase 5 (ERK5) enhances metastatic burden in triple-negative breast cancer through focal adhesion protein kinase (FAK)-mediated regulation of cell adhesion.

Authors:  Qiuping Xu; Jingwei Zhang; Brian A Telfer; Hao Zhang; Nisha Ali; Fuhui Chen; Blanca Risa; Adam J Pearson; Wei Zhang; Katherine G Finegan; Ahmet Ucar; Emanuele Giurisato; Cathy Tournier
Journal:  Oncogene       Date:  2021-05-12       Impact factor: 9.867

6.  ERα-XPO1 Cross Talk Controls Tamoxifen Sensitivity in Tumors by Altering ERK5 Cellular Localization.

Authors:  Kinga Wrobel; Yiru Chen Zhao; Eylem Kulkoyluoglu; Karen Lee Ann Chen; Kadriye Hieronymi; Jamie Holloway; Sarah Li; Tania Ray; Partha Sarathi Ray; Yosef Landesman; Alexander Edward Lipka; Rebecca Lee Smith; Zeynep Madak-Erdogan
Journal:  Mol Endocrinol       Date:  2016-08-17

Review 7.  Translational Significance for Tumor Metastasis of Tumor-Associated Macrophages and Epithelial-Mesenchymal Transition.

Authors:  Wenzhe Song; Roberta Mazzieri; Tao Yang; Glenda C Gobe
Journal:  Front Immunol       Date:  2017-09-13       Impact factor: 7.561

Review 8.  The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells.

Authors:  Alexandra C Kölbl; Udo Jeschke; Ulrich Andergassen
Journal:  Int J Mol Sci       Date:  2016-08-11       Impact factor: 5.923

Review 9.  Circulating tumor cells in breast cancer.

Authors:  Francois-Clement Bidard; Charlotte Proudhon; Jean-Yves Pierga
Journal:  Mol Oncol       Date:  2016-01-12       Impact factor: 6.603

10.  DCLK1 is correlated with MET and ERK5 expression, and associated with prognosis in malignant pleural mesothelioma.

Authors:  Hui Wang; Yu-Yuan Dai; Wen-Qian Zhang; Ping-Chih Hsu; Yi-Lin Yang; Yu-Cheng Wang; Geraldine Chan; Alfred Au; Zhi-Dong Xu; Shu-Juan Jiang; Wei Wang; David M Jablons; Liang You
Journal:  Int J Oncol       Date:  2017-05-26       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.